
Revelation Biosciences, Inc.
REVBHealthcare|Biotechnology|US
$3.89
+0.33 (+9.27%)
DCF Value
$106.03
Tangible Book / Share
$12.93
Cash / Share
$16.30
Next Earnings Report
Apr 1, 2027
EPS est. -$5.99
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Feb 11, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Revelation Biosciences, Inc. Announces Financial Results For the Three and Nine Months Ended September 30, 2026
Nov 5, 2026 · Business Wire
Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026
Oct 16, 2026 · Business Wire
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study
Aug 19, 2026 · Business Wire
SEC Filings (78)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Nov 5, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 19, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 6, 2026 | 8-K | Material event | DocumentIndex |
| Aug 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 13, 2026 | 8-A12B | DocumentIndex | |
| Jul 13, 2026 | 8-K | Material event | DocumentIndex |
| Jun 24, 2026 | 8-K | Material event | DocumentIndex |
| Jun 1, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 11, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| May 11, 2026 | ARS | Annual report to holders | DocumentIndex |
| May 7, 2026 | 8-K | Material event | DocumentIndex |
| May 7, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Apr 30, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 15, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 19, 2026 | 8-K | Material event | DocumentIndex |
| Feb 26, 2026 | 8-K | Material event | DocumentIndex |
| Feb 26, 2026 | 10-K | Annual report | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Feb 11, 2026 | EFFECT | DocumentIndex | |
| Feb 11, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Feb 6, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Jan 30, 2026 | S-3 | Shelf registration | DocumentIndex |
| Jan 29, 2026 | 8-K | Material event | DocumentIndex |
| Jan 22, 2026 | 8-K | Material event | DocumentIndex |
| Jan 20, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Dec 3, 2025 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Nov 12, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Nov 10, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Nov 6, 2025 | 8-K | Material event | DocumentIndex |
| Nov 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Oct 30, 2025 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Oct 29, 2025 | 8-K | Material event | DocumentIndex |
| Oct 15, 2025 | 8-K | Material event | DocumentIndex |
| Sep 30, 2025 | EFFECT | DocumentIndex | |
| Sep 30, 2025 | 424B3 | Offering prospectus | DocumentIndex |